BRIEF published on 10/03/2024 at 18:35, 3 days 17 hours ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 7 days 4 hours ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
PRESS RELEASE published on 09/30/2024 at 07:30, 7 days 4 hours ago Inside Information / Other news releases Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF published on 09/09/2024 at 07:35, 28 days 4 hours ago POXEL announces a significant increase in its sales in the second quarter of 2024 Sales Treasury Partnerships TWYMEEG® Poxel
BRIEF published on 08/16/2024 at 08:16, 1 month 22 days ago Poxel: Evolution of the Share Capital and the Number of Voting Rights Share Capital Voting Rights Actions AMF Poxel
BRIEF published on 08/07/2024 at 08:05, 2 months ago Sumitomo Pharma and Poxel Unveil Study Results of TWYMEEG® for Type 2 Diabetes TWYMEEG® Poxel Sumitomo Pharma Type 2 Diabetes Renal Failure
PRESS RELEASE published on 08/07/2024 at 08:00, 2 months ago Inside Information / Other news releases Sumitomo Pharma and Poxel announce topline results from post-marketing clinical study on TWYMEEG(R) for Type 2 Diabetes treatment in Japan. Safety, tolerability confirmed in renal impairment patients Japan Poxel Sumitomo Pharma Type 2 Diabetes TWYMEEG
Published on 10/07/2024 at 12:00, 28 minutes ago HireRoad Adds Senior HR Executive, Best-Selling Author, and HR Thought Leader Steve Pemberton to Board of Directors
Published on 10/07/2024 at 09:05, 3 hours 23 minutes ago Terry Lynch Joins BioNxt as Capital Markets Advisor
Published on 10/07/2024 at 08:00, 4 hours 28 minutes ago Re-Inventing the Runway - Immersive Exhibition Launch
Published on 10/05/2024 at 04:00, 2 days 8 hours ago Agents Amazed by Incredible New Benefits Announced at Epique Realty Livestream Event
Published on 10/05/2024 at 03:30, 2 days 8 hours ago Agents Excited by Transformative Company Announcements at Epique Realty Livestream Event
Published on 10/07/2024 at 12:00, 28 minutes ago thyssenkrupp nucera Receives HBJ Best Places to Work Award
Published on 10/07/2024 at 12:00, 28 minutes ago Walls & Futures REIT PLC: Result of 2024 AGM - CORRECTION
Published on 10/07/2024 at 11:45, 43 minutes ago Twelfth acquisition in 2024: Mutares submits a binding offer to acquire Alcura France from Alliance Healthcare Group France
Published on 10/07/2024 at 11:30, 58 minutes ago GZO AG: Creditor group receives broad support for its proposals to save the Wetzikon Hospital from bankruptcy
Published on 10/07/2024 at 11:05, 1 hour 22 minutes ago 2CRSi SA: Monthly information regarding the total number of voting rights and shares comprising the share capital as of September 30, 2024
Published on 10/07/2024 at 10:41, 1 hour 46 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From September 30th 2024 to October 4th 2024
Published on 10/04/2024 at 18:27, 2 days 18 hours ago Total number of voting rights and shares making up the share capital at September 30, 2024
Published on 10/04/2024 at 18:00, 2 days 18 hours ago Information concerning the total number of voting rights and shares in the share capital as of September 30, 2024
Published on 10/03/2024 at 17:45, 3 days 18 hours ago Aéroports de Paris SA - Voting rights as of 30 September 2024
Published on 10/03/2024 at 17:45, 3 days 18 hours ago CHARGEURS - Voting rights monthly statement as of September 30th, 2024